UP0047UP0065bepranemabNCT03605082tauopathies
… (PBPK/PD) model was developed to predict dose response.Results UP0047: Caucasian participants (N=52) were randomised to bepranemab 0.…
1articles mentioning institutions
2institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: UP0047 ×
UP0047
This institution is selected. Its supporting articles are shown below.